Impact of Corticosteroids on Efficacy of BCMA Targeted CAR-T Therapy in Multiple Myeloma

被引：2
作者：
Duvalyan, Eva [1 ]
Lo, Mimi [2 ]
Martin, Thomas [3 ]
Wolf, Jeffrey L. [3 ]
Chung, Alfred [3 ]
Arora, Shagun [3 ]
Shah, Nina [3 ]
Huang, Chiung-Yu [3 ]
Wong, Sandy W. [3 ]
机构：
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Pharmaceut Serv, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146678
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1759
引用
收藏
页数：5
相关论文
共 50 条
  • [21] DIRECTED IMMUNOTHERAPY: CAR-T STUDY AGAINST BCMA FOR THE TREATMENT OF MULTIPLE MYELOMA
    Perez Amill, L.
    Sune, G.
    Castella, M.
    Urbano Ispizua, A.
    Martin Antonio, B.
    HAEMATOLOGICA, 2017, 102 : 52 - 52
  • [22] Mathematical modeling of targeted radionuclide therapy and CAR-T cell immunotherapy for maximizing therapeutic efficacy in multiple myeloma
    Adhikarla, Vikram
    Awuah, Dennis
    Caserta, Enrico
    Minnix, Megan
    Kuznetsov, Maxim
    Krishnan, Amrita
    Wong, Jeffrey Y.
    Shively, John E.
    Wang, Xiuli
    Pichiorri, Flavia
    Rockne, Russell C.
    CANCER RESEARCH, 2024, 84 (06)
  • [23] FDA approves first BCMA-targeted CAR-T cell therapy
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (05) : 332 - 332
  • [24] FDA approves first BCMA-targeted CAR-T cell therapy
    Asher Mullard
    Nature Reviews Drug Discovery, 2021, 20 : 332 - 332
  • [25] High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma
    Tang, Yuanyan
    Yin, Haisen
    Zhao, Xinying
    Jin, Dan
    Liang, Yan
    Xiong, Tao
    Li, Lu
    Tang, Wen
    Zhang, Jiangzhao
    Liu, Min
    Yu, Zhuojun
    Liu, Huimin
    Zang, Sibin
    Huang, Zhiping
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [26] High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma
    Yuanyan Tang
    Haisen Yin
    Xinying Zhao
    Dan Jin
    Yan Liang
    Tao Xiong
    Lu Li
    Wen Tang
    Jiangzhao Zhang
    Min Liu
    Zhuojun Yu
    Huimin Liu
    Sibin Zang
    Zhiping Huang
    Journal of Experimental & Clinical Cancer Research, 41
  • [27] CAR-T Therapy in Relapsed Refractory Multiple Myeloma
    Ding, Hong
    Wu, Yu
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (27) : 4362 - 4382
  • [28] FDA approves second BCMA-targeted CAR-T cell therapy
    Asher Mullard
    Nature Reviews Drug Discovery, 2022, 21 : 249 - 249
  • [29] A new CAR-T cell therapy for multiple myeloma
    Hosen, Naoki
    CANCER SCIENCE, 2022, 113 : 644 - 644
  • [30] CAR-T Therapy in Multiple Myeloma: Looking Beyond
    Maiorana, Gianluca
    Antolino, Giusy
    La Verde, Giacinto
    Tafuri, Agostino
    HEMATO, 2024, 5 (02): : 180 - 198
12345